Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Clare-Salzler

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Autoimmunity Reviews|August 8, 2006
Dendritic cell subsets and type I diabetes: focus upon DC-based therapyJeannette Lo, Michael J Clare-Salzler
Biomaterials|May 30, 2009
A high-throughput microparticle microarray platform for dendritic cell-targeting vaccinesAbhinav P Acharya, Michael J Clare-Salzler, Benjamin G Keselowsky
Current Opinion in Organ Transplantation|May 16, 2009
Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cellsChang-Qing Xia, Kim A Campbell, Michael J Clare-Salzler
Biochemical and Biophysical Research Communications|December 13, 2006
Dendritic cells post-maturation are reprogrammed with heightened IFN-gamma and IL-10Chang-Qing Xia, Ruihua Peng, Mani Annamalai, et al.
Journal of Immunology Research|April 14, 2018
Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic MiceJeannette Lo, Chang-Qing Xia, Ruihua Peng, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesisMatthew R Murawski, Sally A Litherland, Michael J Clare-Salzler, et al.
Biomaterials|October 3, 2008
Adhesive substrate-modulation of adaptive immune responsesAbhinav P Acharya, Natalia V Dolgova, Michael J Clare-Salzler, et al.
Journal of Blood Disorders & Transfusion|January 19, 2016
Characterization of Bone Marrow-Derived Dendritic Cells Developed in Serum-Free Media and their Ability to Prevent Type 1 Diabetes in Nonobese Diabetic MiceBen M Looney, Anna V Chernatynskaya, Michael J Clare-Salzler, et al.
Thyroid : Official Journal of the American Thyroid Association|December 31, 2010
Parvovirus B19 infection in Hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinomaLaura A Adamson, Larry J Fowler, Michael J Clare-Salzler, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetesJeannette Lo, Rui Hua Peng, Tolga Barker, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Autoimmunity Reviews|August 8, 2006
Dendritic cell subsets and type I diabetes: focus upon DC-based therapyJeannette Lo, Michael J Clare-Salzler
Biomaterials|May 30, 2009
A high-throughput microparticle microarray platform for dendritic cell-targeting vaccinesAbhinav P Acharya, Michael J Clare-Salzler, Benjamin G Keselowsky
Current Opinion in Organ Transplantation|May 16, 2009
Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cellsChang-Qing Xia, Kim A Campbell, Michael J Clare-Salzler
Biochemical and Biophysical Research Communications|December 13, 2006
Dendritic cells post-maturation are reprogrammed with heightened IFN-gamma and IL-10Chang-Qing Xia, Ruihua Peng, Mani Annamalai, et al.
Journal of Immunology Research|April 14, 2018
Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic MiceJeannette Lo, Chang-Qing Xia, Ruihua Peng, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesisMatthew R Murawski, Sally A Litherland, Michael J Clare-Salzler, et al.
Biomaterials|October 3, 2008
Adhesive substrate-modulation of adaptive immune responsesAbhinav P Acharya, Natalia V Dolgova, Michael J Clare-Salzler, et al.
Journal of Blood Disorders & Transfusion|January 19, 2016
Characterization of Bone Marrow-Derived Dendritic Cells Developed in Serum-Free Media and their Ability to Prevent Type 1 Diabetes in Nonobese Diabetic MiceBen M Looney, Anna V Chernatynskaya, Michael J Clare-Salzler, et al.
Thyroid : Official Journal of the American Thyroid Association|December 31, 2010
Parvovirus B19 infection in Hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinomaLaura A Adamson, Larry J Fowler, Michael J Clare-Salzler, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetesJeannette Lo, Rui Hua Peng, Tolga Barker, et al.
Pageof 6